David Wright ^UDM

David Wright, as CTO and Founder of Kuano, leads the development of the Nautilus platform, integrating AI and quantum simulation for drug design and discovery. Kuano's innovative approach, combining target quantum mapping with AI-led chemistry, accelerates the development of effective drug candidates. Wright's work in generating superior enzyme inhibitors through targeting Quantum Transition States is pivotal in improving drug quality and reducing discovery time.